Tuberculosis (Edinburgh, Scotland) · 2013
Weakly positive tests and chronologic variation of the QuantiFERON assay: a retrospective appraisal of usefulness.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Felber Anja, Graninger Winfried
Аннотация
OBJECTIVES: QuantiFERON Tb Gold IT (QFT) is routinely used as diagnostic tool for detecting immune reactivity towards Mycobacterium tuberculosis. When diagnosing a latent infection weakly positive results and test reproducibility must be considered.
PURPOSE: To judge the frequency of useful information versus confusion gained by QFT in patients with immune-mediated diseases and in pulmonary outpatients.
METHODS: We retrospectively analysed 1485 QFT-tests performed on 855 patients with autoimmune diseases prior to initiating biologics and on 447 pulmonary outpatients with a suspected tuberculosis infection over a period of 16 months. In 161 cases the IGRA test was erroneously repeated. After 18 months clinical, radiographic and bacteriologic evidence for tuberculosis was collected.
RESULTS: Of all 1485 QFT-tests 247 (=16.63%) showed a positive result, 1186 (79.87%) were negative and 52 (3.50%) turned out to be indeterminate. Using the manufacturers cut-off value for the interferon-γ response, a cohort (n = 64) of weakly positive individuals (26% of all positives) was apparent. Repeated testing within ten weeks yielded negative reactivity in 69% of these patients. Of 25 IGRA positive patients who had a repeat test after one year without tuberculosis medication, 48% showed a reversion to a negative test. The frequency of indeterminate results of the IGRA was satisfying (3.5%).
CONCLUSION: In case of only slightly elevated immune reactivity quantitative reporting of positive QFT-test results and a repeat test strategy might be of advantage for the usefulness of the test.
PURPOSE: To judge the frequency of useful information versus confusion gained by QFT in patients with immune-mediated diseases and in pulmonary outpatients.
METHODS: We retrospectively analysed 1485 QFT-tests performed on 855 patients with autoimmune diseases prior to initiating biologics and on 447 pulmonary outpatients with a suspected tuberculosis infection over a period of 16 months. In 161 cases the IGRA test was erroneously repeated. After 18 months clinical, radiographic and bacteriologic evidence for tuberculosis was collected.
RESULTS: Of all 1485 QFT-tests 247 (=16.63%) showed a positive result, 1186 (79.87%) were negative and 52 (3.50%) turned out to be indeterminate. Using the manufacturers cut-off value for the interferon-γ response, a cohort (n = 64) of weakly positive individuals (26% of all positives) was apparent. Repeated testing within ten weeks yielded negative reactivity in 69% of these patients. Of 25 IGRA positive patients who had a repeat test after one year without tuberculosis medication, 48% showed a reversion to a negative test. The frequency of indeterminate results of the IGRA was satisfying (3.5%).
CONCLUSION: In case of only slightly elevated immune reactivity quantitative reporting of positive QFT-test results and a repeat test strategy might be of advantage for the usefulness of the test.